(Q30352116)

17 October 2017

HIV vaccine acceptability among communities at risk: the impact of vaccine characteristics (English)

1 reference

17 October 2017

1 reference

1

1 reference

17 October 2017

Naihua Duan

2

1 reference

17 October 2017

Sung-Jae Lee

3

1 reference

17 October 2017

Ellen T Rudy

4

1 reference

17 October 2017

Danielle S Seiden

5

1 reference

17 October 2017

Lisa Kakinami

6

1 reference

17 October 2017

William E Cunningham

7

1 reference

17 October 2017

language of work or name

English

0 references

publication date

21 November 2005

1 reference

17 October 2017

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

17 October 2017

24

1 reference

17 October 2017

12

1 reference

17 October 2017

2094-2101

1 reference

HIV vaccine acceptability among women at risk: perceived barriers and facilitators to future HIV vaccine uptake

17 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Challenges for HIV vaccine dissemination and clinical trial recruitment: if we build it, will they come?

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Posttrial HIV vaccine adoption: concerns, motivators, and intentions among persons at risk for HIV.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

HIV risk and prevention in a post-vaccine context

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Jump-starting the immune system: prime-boosting comes of age.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Medicine. The need for a global HIV vaccine enterprise

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Estimation of ?needs? and ?probable uptake? for HIV/AIDS preventive vaccines based on possible policies and likely acceptance (a WHO/UNAIDS/IAVI study)

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Measuring preferences for health care interventions using conjoint analysis: an application to HIV testing

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Development of an oral prime-boost strategy to elicit broadly neutralizing antibodies against HIV-1.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

The acceptability of HIV immunization: examining vaccine characteristics as determining factors

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Using conjoint analysis to elicit preferences for health care

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

HIV immunization: acceptability and anticipated effects on sexual behavior among adolescents.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Low-efficacy HIV vaccines: potential for community-based intervention programmes

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Key issues for a potential human immunodeficiency virus vaccine

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Why do gay men want to be vaccinated against hepatitis B? An assessment of psychosocial determinants of vaccination intention.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Modeling choice behavior for new pharmaceutical products.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

What can be achieved with an HIV vaccine?

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Calling the shots: immunization finance policies and practices. Executive summary of the report of the Institute of Medicine.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Advancing AIDSVAX to phase 3. Safety, immunogenicity, and plans for phase 3.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Attitudes about human immunodeficiency virus immunization: the influence of health beliefs and vaccine characteristics

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2819665

Clinical research. A setback and an advance on the AIDS vaccine front

26 November 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.013

HIV/AIDS. Vaccine results lose significance under scrutiny

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.013

Racial/ethnic differences in influenza vaccination coverage in high-risk adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.013

Social-cognitive determinants of vaccination behavior against hepatitis B: an assessment among men who have sex with men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.013

Exploring hepatitis B vaccination acceptance among young men who have sex with men: facilitators and barriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.013

Vaccine characteristics and acceptability of HIV immunization among adolescents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.013

Delays and unmet need for health care among adult primary care patients in a restructured urban public health system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.013

Simultaneous conjoint measurement: A new type of fundamental measurement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.013

Methodological issues in the application of conjoint analysis in health care

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.013

AIDSVAX results: an answer, or just more questions?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.013

The estimated prevalence and incidence of HIV in 96 large US metropolitan areas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.013

Vaccinations in adults: missed opportunities

7 January 2021

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16332402

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Candidate HIV/AIDS vaccines: lessons learned from the World's first phase III efficacy trials

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16332402

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.11.013

1 reference

17 October 2017

1 reference

17 October 2017

PubMed publication ID

16332402

1 reference